FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038176989> ?p ?o ?g. }

• W2038176989 endingPage "404" @default.
• W2038176989 startingPage "404" @default.
• W2038176989 abstract "Editorial Notes1 March 1981Calcifediol (25-Hydroxyvitamin D3) in the Treatment of Uremic Bone DiseaseSTEVEN L. TEITELBAUM, M.D.STEVEN L. TEITELBAUM, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-94-3-404 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptRenal osteodystrophy is a generic term referring to the many morphologic and biochemical abnormalities of the skeleton in uremia. Although various combinations exist, the basic histologic features of the disorder are those of osteitis fibrosa (which reflects hyperparathyroidism) and osteomalacia (or defective mineralization).Within the past two decades, a great deal of information has accumulated on the pathogenesis of uremic bone disease (1). For example, the severity of the secondary hyperparathyroidism accompanying renal failure is clearly related to various factors, not the least of which are hyperphosphatemia and hypocalcemia. Consequently, therapy has been directed toward controlling blood phosphorus levels by...References1. AVIOLITEITELBAUM LS. Renal osteodystrophy. In: EARLEY LE, GOTTSCHALK CW, eds. Strauss and Welt's Diseases of the Kidney. 3rd ed. Boston: Little, Brown and Co.; 1979:307-70. Google Scholar2. AVIOLIBIRGELEESLATOPOLSKY LSSE. The metabolic fate of vitamin D3-3H in chronic renal failure. J Clin Invest. 1966;47:2239-52. CrossrefGoogle Scholar3. POTTERWILSONOZONOFF DCM. Hyperparathyroid bone disease in children undergoing long-term hemodialysis; treatment with vitamin D. J Pediatr. 1974;85:60-6. CrossrefMedlineGoogle Scholar4. TEITELBAUMHRUSKASHIEBERDEBNAMNICHOLS SKWJS. Tetracycline fluorescence in uremic and primary hyperparathyroid bone. Kidney Int. 1977;12:366-72. CrossrefMedlineGoogle Scholar5. EISMANHAMSTRAKREAMDELUCA JABH. 1,25-dihydroxyvitamin D in biological fluids: a simplified and sensitive assay. Science. 1976;193:1021-3. CrossrefMedlineGoogle Scholar6. BRICKMANCOBURNNORMAN AJA. Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3, in uremic man. N Engl J Med. 1972;287;891-5. CrossrefMedlineGoogle Scholar7. RECKERSCHOENFELDLETTERISLATOPOLSKYGOLDSMITHBRICKMAN RPJERA. The efficacy of calcifediol in renal osteodystrophy. Arch Intern Med. 1978;138:857-63. CrossrefMedlineGoogle Scholar8. TEITELBAUMBONESTEIN SJP. Calcifediol in chronic renal insufficiency: skeletal response. JAMA. 1976;235:164-7. CrossrefMedlineGoogle Scholar9. FROSTGRIFFITHJEEKIMMELMCCANDLISTEITELBAUM HDWDRS. Histomorphometric changes in trabecular bone of renal failure patients treated with calcifediol. Metab Bone Dis Related Res. In press. Google Scholar10. BORDIERZINGRAFFGUERIS PJJ. The effect of 1α(OH)D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy. Am J Med. 1978;64:101-7. CrossrefMedlineGoogle Scholar11. PIERIDESELLISSIMPSONDEWARWARDKERR AHWJMD. Variable response to long-term 1α-hydroxycholecalciferol in haemodialysis osteodystrophy. Lancet. 1976;1:1092-5. CrossrefMedlineGoogle Scholar12. RUTHERFORDBORDIERMARIE WPP. Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J Clin Invest. 1977;60:332-41. CrossrefMedlineGoogle Scholar13. TEITELBAUMBERGFELDFREITAGHRUSKASLATOPOLSKY SMJKE. Do parathyroid hormone and 1,25-dihydroxyvitamin D modulate bone formation in uremia? J Clin Endocrinol Metab. 1980;51:247-51. CrossrefMedlineGoogle Scholar14. ELLISMCCARTHYHERRINGTON HJJ. Bone aluminum in haemodialyzed patients and in rats injected with aluminum chloride: relationship to impaired bone mineralisation. J Clin Pathol. 1979;32:832-44. CrossrefMedlineGoogle Scholar15. HEALYMALLUCHEGOLDSTEINSINGERMASSRY MHDFS. Effects of long-term therapy with calcitriol in patients with moderate renal failure. Arch Intern Med. 1980;140:1030-3. CrossrefMedlineGoogle Scholar16. HOLICKDE BLANCOCLARK MMM. The metabolism of [6-3H]1α, 25-dihydroxycholecaliferol to [6-3H]1α, 25-dihydroxycholecalciferol in a patient with renal insufficiency. J Clin Endocrinol Metab. 1977;44:595-8. CrossrefMedlineGoogle Scholar17. HADDADROJANASATHIT JS. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab. 1976;42:284-90. CrossrefMedlineGoogle Scholar18. CHRISTIANSENRøDBROCHRISTENSENHARTNACKTRANSBøL CPMBI. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet. 1978;2:700-3. CrossrefMedlineGoogle Scholar19. TOUGAARDSøRENSENBRøCHNER-MORTENSENCHRISTENSENRøDBROSøRENSEN LEJMPA. Controlled trial of 1α-hydroxycholecalcalciferol in chronic renal failure. Lancet. 1976;1:1044-7. CrossrefMedlineGoogle Scholar20. MASSRYGOLDSTEIN SD. Is calcitriol [1,25(OH)2D3] harmful to renal function? JAMA. 1979;242:1875-6. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Division of Bone and Mineral Metabolism and Department of Pathology and Laboratory Medicine The Jewish Hospital of St. Louis Washington University School of Medicine St. Louis, Missouri PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByManagement of chronic renal failure in childrenReview: Renal Osteodystrophy—Pathogenesis TreatmentRenal Osteodystrophy—Pathogenesis and TreatmentCalcium regulation 1 March 1981Volume 94, Issue 3Page: 404-405KeywordsBloodBoneHyperparathyroidismHypocalcemiaPathogenesisPhosphorusRenal diseasesRenal failureSkeleton Issue Published: 1 March 1981 PDF DownloadLoading ..." @default.
• W2038176989 created "2016-06-24" @default.
• W2038176989 creator A5001716316 @default.
• W2038176989 date "1981-03-01" @default.
• W2038176989 modified "2023-10-14" @default.
• W2038176989 title "Calcifediol (25-Hydroxyvitamin D3) in the Treatment of Uremic Bone Disease" @default.
• W2038176989 cites W1976907026 @default.
• W2038176989 cites W1986410326 @default.
• W2038176989 cites W1991176050 @default.
• W2038176989 cites W1991889710 @default.
• W2038176989 cites W2002002429 @default.
• W2038176989 cites W2009853287 @default.
• W2038176989 cites W2018503603 @default.
• W2038176989 cites W2066569249 @default.
• W2038176989 cites W2072397197 @default.
• W2038176989 cites W2075943427 @default.
• W2038176989 cites W2081849227 @default.
• W2038176989 cites W2092884029 @default.
• W2038176989 cites W2115891408 @default.
• W2038176989 cites W2143006777 @default.
• W2038176989 cites W2147190745 @default.
• W2038176989 cites W2338582714 @default.
• W2038176989 doi "https://doi.org/10.7326/0003-4819-94-3-404" @default.
• W2038176989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6894359" @default.
• W2038176989 hasPublicationYear "1981" @default.
• W2038176989 type Work @default.
• W2038176989 sameAs 2038176989 @default.
• W2038176989 citedByCount "5" @default.
• W2038176989 crossrefType "journal-article" @default.
• W2038176989 hasAuthorship W2038176989A5001716316 @default.
• W2038176989 hasConcept C124490489 @default.
• W2038176989 hasConcept C126322002 @default.
• W2038176989 hasConcept C134018914 @default.
• W2038176989 hasConcept C141071460 @default.
• W2038176989 hasConcept C2775945674 @default.
• W2038176989 hasConcept C2776036575 @default.
• W2038176989 hasConcept C2776169692 @default.
• W2038176989 hasConcept C2776541429 @default.
• W2038176989 hasConcept C2776556354 @default.
• W2038176989 hasConcept C2776635150 @default.
• W2038176989 hasConcept C2776699218 @default.
• W2038176989 hasConcept C2777736040 @default.
• W2038176989 hasConcept C2778049618 @default.
• W2038176989 hasConcept C2778063415 @default.
• W2038176989 hasConcept C2778653478 @default.
• W2038176989 hasConcept C2778838027 @default.
• W2038176989 hasConcept C2779240191 @default.
• W2038176989 hasConcept C2780551157 @default.
• W2038176989 hasConcept C2781208988 @default.
• W2038176989 hasConcept C2781343496 @default.
• W2038176989 hasConcept C519063684 @default.
• W2038176989 hasConcept C71924100 @default.
• W2038176989 hasConcept C90924648 @default.
• W2038176989 hasConceptScore W2038176989C124490489 @default.
• W2038176989 hasConceptScore W2038176989C126322002 @default.
• W2038176989 hasConceptScore W2038176989C134018914 @default.
• W2038176989 hasConceptScore W2038176989C141071460 @default.
• W2038176989 hasConceptScore W2038176989C2775945674 @default.
• W2038176989 hasConceptScore W2038176989C2776036575 @default.
• W2038176989 hasConceptScore W2038176989C2776169692 @default.
• W2038176989 hasConceptScore W2038176989C2776541429 @default.
• W2038176989 hasConceptScore W2038176989C2776556354 @default.
• W2038176989 hasConceptScore W2038176989C2776635150 @default.
• W2038176989 hasConceptScore W2038176989C2776699218 @default.
• W2038176989 hasConceptScore W2038176989C2777736040 @default.
• W2038176989 hasConceptScore W2038176989C2778049618 @default.
• W2038176989 hasConceptScore W2038176989C2778063415 @default.
• W2038176989 hasConceptScore W2038176989C2778653478 @default.
• W2038176989 hasConceptScore W2038176989C2778838027 @default.
• W2038176989 hasConceptScore W2038176989C2779240191 @default.
• W2038176989 hasConceptScore W2038176989C2780551157 @default.
• W2038176989 hasConceptScore W2038176989C2781208988 @default.
• W2038176989 hasConceptScore W2038176989C2781343496 @default.
• W2038176989 hasConceptScore W2038176989C519063684 @default.
• W2038176989 hasConceptScore W2038176989C71924100 @default.
• W2038176989 hasConceptScore W2038176989C90924648 @default.
• W2038176989 hasIssue "3" @default.
• W2038176989 hasLocation W20381769891 @default.
• W2038176989 hasLocation W20381769892 @default.
• W2038176989 hasOpenAccess W2038176989 @default.
• W2038176989 hasPrimaryLocation W20381769891 @default.
• W2038176989 hasRelatedWork W1999679087 @default.
• W2038176989 hasRelatedWork W2009354171 @default.
• W2038176989 hasRelatedWork W2023378773 @default.
• W2038176989 hasRelatedWork W2070682671 @default.
• W2038176989 hasRelatedWork W2131074353 @default.
• W2038176989 hasRelatedWork W2256036970 @default.
• W2038176989 hasRelatedWork W2257800414 @default.
• W2038176989 hasRelatedWork W2394771687 @default.
• W2038176989 hasRelatedWork W2429458090 @default.
• W2038176989 hasRelatedWork W4306151998 @default.
• W2038176989 hasVolume "94" @default.
• W2038176989 isParatext "false" @default.
• W2038176989 isRetracted "false" @default.
• W2038176989 magId "2038176989" @default.
• W2038176989 workType "article" @default.